Conference Series is beaming to invite all the experts in the field of Biomarkers for the forthcoming event “15^th Global Biomarkers Summit” which is going to be grasp on March 20-21, 2019 at Paris, France.

The Global Biomarkers Summit Conference is the brainchild of the top Technology firms in the theme of “Challenges  and opportunities in incorporating Biomarker research”.This opportunity brings together the best of brains for some roundtable discussions on the direction and flow of technology for the nation and the world in the next decade.

Global Biomarkers Summit and all Biomarkers meeting, Biological occasions will help in structures association, B2B collaborations  in the midst of executives  and academicians. We have managed different energizing Biomarkers occasions bringing the scientists and affiliations together.This Global Biomarkers Summit addresses the latest trends and technological  developement in the fields of biomarkers in drug delivery, biomarkers in drug safety, genetic biomarkers, biomarkers applications in Nano science, challenges of clinical translation, Companion Diagnostics,Cell freeBiomarkers in Disease diagnosis & prognosis etc.

20+ sessions for the participation of Keynote, Plenary talk, oral, Young Research Forum, Video presentation, Poster presentation and e-poster. This creates  a new  platform for the participants  by building up networks between them.

We would be delighted to have your presence at this conference to hear, technology advancements and their impact on our research and daily lives. We would also love to hear your thoughts and opinions towards  this direction.

Who Should Attend?

The Global biomarkers summit is a special discussion to unite worldwide recognized scholastics in the field of Oncology, pharmacology, General wellbeing experts, to trade about best in class of research and advances. All the Deans, Head of Departments, Professors,Associate professors, Assistant professors, PhD scholars ,doctorates, Industry Scientist,Clinical technician, Students, Doctors, Scholastic researchers and Other Professionals from Pharmaceutical and Bio-pharma companies belonging to the  following fields are encouraged.

• Immunology Biomarkers
• Imaging Biomarkers
• Clinical Biomarkers
• Digital Biomarkers
• Oncologist
• Clinical and Radiation oncologist
• Radiation therapist
• Pharmacologist
• Molecular Biomarkers
• Medical physicist
• Genetic researchers
• Drug discovery Biomarkers
• Biopharma researchers
• Medical oncologist
• Molecular Biologist
• Immunologist
• Immunotheraphist
• Biotechnology professional
• Bioengineers
• Medical genetics and cancer epidemiologist
• Bioanalyzers and Bioinformatics
• Oncologist Biomarkers
• Lupus Biomarkers
• Business and marketing under Biopharma
• Genetics and cell Biologist
• Cancer information specialist
• Pathologist
• Hematologist
• Neurologist
• Microbiologist
• Cancer research analyzer
• Biomedical scientist
• Biotech entrepreneur
• Genetic Engineering
• Cell culture and Stem cell researcher
• Molecular and cell biologist
• Biochemist
• Cancer biologist and all biomarker associates.

• 25+ experts from both industry & Academia presenting their research work in Biomarkers.
• Update yourself to latest regulatory guidelines and approvals in Biomarker research.
• Live case studies from pioneers who developed & created a Biomarker.
• Engage yourself into the networking sessions for quality interactions.
• Best platform to promote collaborative research & initiate long-lasting Business partnerships.
• Apply the latest developments in Biomarker into your clinical practice.
• World-class platform to Exhibit the products and services.
• One to one sessions by Biomarker experts across the globe.
• Be a part of the interactive debates, plenary sessions and share your current experience in Biomarker  with fellow colleagues.
• Promoting student into a Biomarker researcher in the way of conducting Young research forum.

• Why Paris, France?

  One out of two men and one out of three Women will be diagnosed with cancer by the time they are 85. In the course of the most recent decade 385,000 new instances of malignant growth were recorded in terrain France. The breakdown was as per the following: 211,000 new cases in men (normal age of 68) and 174,000 cases in Women(normal age of 67).

  The rate of malignancy in men dropped by 1.3% per year somewhere in the range of 2005 and 2012 in any case, it ascended by 0.2% per year in Women. Mortality likewise diminished over a similar period. Male mortality diminished by 2.9% and female mortality by 1.4%. 149,500 individuals kicked the bucket of malignant growth: 84,100 men at a middle age of 73 and 65,400 Women at a middle age of 77.

  The disclosure of new biomarkers and their interpretation into wellbeing intercessions are essential to address the difficulties presented by Human sicknesses in Paris.Better instruments are unequivocally required for the discovery and reconnaissance of illnesses at the epidemiological level and in addition the finding and observing of diseases and conditions at the clinical level. Their improvement, will be progressively critical in the coming of customized prescription.